Poitras Out to Start Season as Bruins Absorb Lower-Body Injury Blow

Matthew Poitras will miss the start of the 2026-27 season. The Boston Bruins announced Sunday that the 22-year-old forward has been placed on injured reserve with a lower-body injury sustained last Tuesday, September 24th. He missed the final three preseason games as a result and will not be available when Boston opens against the New York Rangers on Tuesday, September 30th. Head coach Marco Sturm expressed optimism about Poitras's recovery trajectory, noting that the player feels better each day and expects him back sooner rather than later.

Poitras entered this season as a development candidate with expanded opportunity. After spending most of last year in the AHL with the Providence Bruins, where he posted 44 points in 65 games, he re-signed on a one-year, two-way deal carrying an $850,000 NHL cap hit. The contract signals the organization's intent to give him a legitimate look at the NHL level—his previous time in Boston (three games, one goal) offered minimal runway to establish himself. This preseason, he appeared in Boston's first game and recorded an assist in a win over Washington, demonstrating early readiness for expanded minutes.

The timing compounds the problem for Boston's forward group. The Bruins' depth remains a longstanding concern, and losing a young forward with legitimate AHL production—particularly one the organization just committed contract resources to developing—creates immediate lineup pressure. Poitras's absence forces early-season adjustments and delays his integration into a rotation that could have used his speed and compete level. The IR placement typically covers a minimum of seven to ten days, placing his earliest return window around early October, meaning he'll miss at least the first 4-6 games depending on recovery.

From a betting lens, this absence narrows Boston's forward depth and may depress team total expectations in early-season contests. Sportsbooks have not yet adjusted opening lines for the Rangers matchup on Tuesday, but any edge on unders tied to Boston's lineup composition becomes vulnerable to fast correction once sharps account for Poitras's absence. The more durable angle emerges if his recovery stretches beyond the initial IR minimum—each additional week out compounds lineup stress and increases the likelihood of sustained underperformance against projected offensive totals. Monitor practice participation in the days leading up to October games; if Poitras remains held out while other injured forwards return, it signals a slower recovery than Sturm's optimistic public messaging suggests, and team totals for Boston's next three to five games warrant examination for under value before the market reprices.